Skip to main content
Premium Trial:

Request an Annual Quote

Agreement Gives Agilent Access to BIA Separations' Bio-monolithic Technology

NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has reached an agreement with BIA Separations that gives it access to BIA Separations’ Convective Interaction Media bio-monolithic technology.
Agilent said it will use the technology to develop HPLC columns with strong and weak ion-exchange phases and a protein A phase.
Access to the technology will enable Agilent to provide "enabling solutions" for the separation of virus particles, plasmid DNA, antibodies and other large biomolecules, said Helen Stimson, Agilent's VP and GM of global columns and supplies solutions.
"This technology, when applied at the analytical scale, will improve bio-drug characterization in development and allow QA/QC and process control labs to better monitor and characterize the production of biologics,” she added.
The partnership will also allow BIA Separations "to focus its marketing and sales efforts on preparative and process scale bio-chromatography applications,” said Ales Strancar, managing director of Klagenfurt, Austria-based BIA.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.